Delivery of pharmaceutical agents via the human insulin receptor
View Patent ↗A humanized murine antibody is provided that binds to the human insulin receptor (HIR). The humanized murine antibody is suitable for use as a Trojan horse to deliver pharmaceutical agents to human organs and tissue that express the HIR. The humanized munne antibody is especially well suited for delivering neuropharmaceutical agents from the blood stream to the brain across the blood brain barrier (BBB). The humanized murine antibody may be genetically fused to the pharmaceutical agent or it may be linked to the pharmaceutical agent using an avidin-biotin conjugation system.
1. A humanized antibody that binds to the human insulin receptor, comprising a V H domain comprising the amino acid sequence of SEQ ID NO:5.
2. A humanized antibody that binds to the human insulin receptor comprising a V L domain comprising the amino acid sequence of SEQ ID NO:6.
3. A humanized antibody that binds to the human insulin receptor, comprising a V H domain comprising the amino acid sequence of SEQ ID NO:5 and a V L domain comprising SEQ ID NO:6.
4. A composition comprising the humanized antibody of claim 1 in a pharmaceutically acceptable carrier.
5. A composition comprising the humanized antibody of claim 2 in a pharmaceutically acceptable carrier.
6. A composition comprising the humanized antibody of claim 3 in a pharmaceutically acceptable carrier.